LATEST NEWS
Prof Richard Scolyer gains strength from widespread support
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
MIA researchers share learnings on global stage at ASCO23
Read more about how the MIA team continues to play a leading role in pushing melanoma research boundaries at ASCO23, the world's leading clinical oncology conference.
Prof Richard Scolyer awarded IAP ‘Distinguished Pathologist’ Medal
Read more about why Prof Richard Scolyer AO received the IAP Distinguished Pathologist Medal and watch his inspiring acceptance speech.
May was a marathon month for melanoma fundraisers!
May was a month of marathon runs to raise funds for melanoma ... and an inspiring children’s art exhibition.
Prof Richard Scolyer AO honoured with ASDP Founders’ Award
This is the highest award from the American Society of Dermatopathology, and recognises Prof Scolyer's significant contribution to the field of #dermatopathology.
April Community Fundraising Activity
The month of April was no exception when it came to innovative community fundraising ideas!
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.
1300
It is estimated 1300
Australians will die from
melanoma this year
30 mins
1 Australian is diagnosed
with melanoma every 30
minutes
90%
If caught early 90% of
melanomas can be cured
by surgery
Age 20-39
Melanoma is the most
common cancer affecting
Australians aged 20 to 39
